New membership provides additional perspectives for improving the quality of care for adults and children with ADHD

The ADHD Expert Consortium, a diverse group of ADHD professionals, held its second annual meeting in Orlando, Fla., to expand on its calls to action for improved ADHD diagnosis and care in the United States. In addition to its 12 founding members, the ADHD Expert Consortium added six new members this year, offering additional perspectives on improving the care pathway for ADHD patients.

The ADHD Expert Consortium is comprised of psychiatrists, psychologists, neurologists, pediatricians, nurse practitioners, neuropsychologists, coaches and patient advocates, all passionate about improving the standard of care for this complex and often misunderstood condition. Consortium experts advocate for several improvements in the diagnostic and treatment process, including standardizing objective ADHD testing measures for more confident and accurate diagnoses, and improving insurance coverage for increased access to ADHD assessment and monitoring tools.

“While there has been heightened awareness around ADHD over the past few years, there is not enough being done to standardize processes and provide more access to patients who may not be getting adequate care,” said Dr. Sara Weisenbach, Chief of Neuropsychology, McLean Hospital and member of the ADHD Expert Consortium. “If we do nothing to improve ADHD care, we are hindering patients and putting them at a higher risk of many obstacles, some of which can be fatal. Children and adults with undiagnosed ADHD are more prone to accidents and injuries; have increased rates of comorbid conditions, like anxiety or depression; increased risk of substance use; and, sadly, increased mortality rates. We must act now.”

Members of the ADHD Expert Consortium actively use FDA-cleared objective ADHD testing measures in their practices and businesses to provide more comprehensive ADHD care in clinics and via telehealth. The leading objective testing provider, Qbtech, has administered more than 600,000 tests worldwide and is used by more than 10,000 clinicians.

“ADHD is a highly complex disorder affecting around 8.4% of children in the U.S. and over 6% of adults,” shared Tony Doyle, Commercial Director at Qbtech. “We are incredibly proud of the work the ADHD Expert Consortium is doing to not only bring more awareness to the difficulties ADHD patients face but to make active change in the system for better treatment and care.”

New members of the 2023 ADHD Expert Consortium come from various backgrounds, enhancing the group’s comprehensive approach to ADHD care. New members include:

• Dr. David Aversa, University Psychiatrist, Quinnipiac University; child, adolescent, forensic and adult psychiatrist
• Dr. Nerissa Bauer, behavioral pediatrician; health services researcher; creator of Teach Me ADHD; CEO of Let’s Talk Kids Health
• Dr. Sarah Cheyette, pediatric neurologist, Palo Alto Medical Foundation
• Elaine Taylor-Klaus, MCC, CPCC, co-founder of ImpactADHD, ImpactAnxiety and ImpactParents
• Dr. Perry Roy, internal medicine specialist, pediatrics, Carolina Attention Specialists
• Dr. Melinda Willingham, board-certified pediatrician, InTouch Pediatrics; Chair of the Committee on Federal Government Affairs, American Academy of Pediatrics

Click here to read the full consensus statement. The group encourages other providers, patients and concerned citizens to add their signatures to the official Call to Action to enact better standards of care for those affected by ADHD.

For more information about Qbtech, visit www.qbtech.com.

About Qbtech

Founded in 2002, Qbtech is a privately-owned Swedish company that has developed leading solutions and products for improving the diagnosis, treatment and follow-up of patients living with ADHD. Qbtech has operations in 13 countries and has offices in Stockholm, Houston, and London. Qbtech is an award-winning company recognized for their innovation, most recently winning the 2022 HSJ Partnership Award for the ‘Best Mental Health Partnership with the NHS’. www.qbtech.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005240/en/